Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanqi Huogu Wan
- Development stage
- Unknown
- Lead developer
- Luoyang Orthopedic-Traumatological Hospital of Henan Province
- Administration
- Oral
01
Overview
Sanqi Huogu Wan is a Traditional Chinese Medicine (TCM) formulation primarily indicated for the treatment of avascular necrosis of the femoral head (ANFH), bone fractures, and osteoarthritis. The preparation is heavily based on the pharmacological properties of *Panax notoginseng* (Sanqi), which contains active ginsenosides and notoginsenosides that promote blood circulation and reduce stasis. In the context of bone necrosis, the drug is reported to stimulate the expression of vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2), facilitating angiogenesis and the recruitment of osteoblasts to the site of injury. It is widely utilized in orthopedic hospitals in China, notably the Henan Province Luoyang Orthopedic Hospital, where it was developed as a specialized clinical preparation to improve joint function and delay the need for surgical intervention.
- Brand names
- Sanqi Huogu Wan
- Other names
- 三七活骨丸Sanqi Huogu Pill
02
Targets
VEGFA (Vascular endothelial growth factor A)BMP2 (Bone morphogenetic protein 2)
Beyond the preview
Go deeper on Sanqi Huogu Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanqi Huogu Wan.